392 related articles for article (PubMed ID: 31555281)
1. STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
Hanlon MM; Rakovich T; Cunningham CC; Ansboro S; Veale DJ; Fearon U; McGarry T
Front Immunol; 2019; 10():2056. PubMed ID: 31555281
[No Abstract] [Full Text] [Related]
2. JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis.
McGarry T; Orr C; Wade S; Biniecka M; Wade S; Gallagher L; Low C; Veale DJ; Fearon U
Arthritis Rheumatol; 2018 Dec; 70(12):1959-1970. PubMed ID: 29790294
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
4. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
[TBL] [Abstract][Full Text] [Related]
5. Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function.
O'Brien A; Hanlon MM; Marzaioli V; Wade SC; Flynn K; Fearon U; Veale DJ
Front Immunol; 2021; 12():672461. PubMed ID: 34248953
[TBL] [Abstract][Full Text] [Related]
6. Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis.
Fromm S; Cunningham CC; Dunne MR; Veale DJ; Fearon U; Wade SM
Arthritis Res Ther; 2019 Dec; 21(1):297. PubMed ID: 31864394
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
8. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
9. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
[TBL] [Abstract][Full Text] [Related]
10. Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis.
Petrasca A; Phelan JJ; Ansboro S; Veale DJ; Fearon U; Fletcher JM
Rheumatology (Oxford); 2020 Oct; 59(10):2816-2828. PubMed ID: 32047926
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts.
Tu HJ; Lin TH; Chiu YC; Tang CH; Yang RS; Fu WM
J Cell Physiol; 2013 May; 228(5):983-90. PubMed ID: 23042533
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis.
Balogh E; Veale DJ; McGarry T; Orr C; Szekanecz Z; Ng CT; Fearon U; Biniecka M
Arthritis Res Ther; 2018 May; 20(1):95. PubMed ID: 29843785
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
[TBL] [Abstract][Full Text] [Related]
14. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice.
van Keulen D; Pouwer MG; Pasterkamp G; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
PLoS One; 2018; 13(10):e0204911. PubMed ID: 30273401
[TBL] [Abstract][Full Text] [Related]
16. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis.
Gao W; McCormick J; Connolly M; Balogh E; Veale DJ; Fearon U
Ann Rheum Dis; 2015 Jun; 74(6):1275-83. PubMed ID: 24525913
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
[TBL] [Abstract][Full Text] [Related]
20. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
